Ledger.Open graph →
SEC Form D · filed August 22, 2019

E25Bio Inc

Offering
$2.3M
Sold
$2.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Anthony Figlia · New York, NYExec · DirectorMichael Mayer · New York, NYDirectorAnand Kumar · Pleasanton, CADirectorAshleigh Rogers · Pleasanton, CAExec · DirectorJeff Takle · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗